Lactase-like Protein/LCTL Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87714
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human Lactase-like Protein/LCTL. Peptide sequence: LLVPRLGAARKGSPEEASFYYGTFPLGFSWGVGSSAYQTEGAWDQDGKGP The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Lactase-like Protein/LCTL Antibody
![Western Blot: Lactase-like Protein/LCTL Antibody [NBP2-87714]](https://resources.bio-techne.com/images/products/Lactase-like-Protein-LCTL-Antibody-Western-Blot-NBP2-87714-img0001.jpg "Western Blot: Lactase-like Protein/LCTL Antibody [NBP2-87714]")
Western Blot: Lactase-like Protein/LCTL Antibody [NBP2-87714]
Western Blot: Lactase-like Protein/LCTL Antibody [NBP2-87714] - Host: Rabbit. Target Name: LCTL. Sample Type: Hela Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for Lactase-like Protein/LCTL Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Lactase-like Protein/LCTL
Alternate Names
KLG, KLPH, Lactase like Protein, LCTL
Gene Symbol
LCTL
Additional Lactase-like Protein/LCTL Products
Product Documents for Lactase-like Protein/LCTL Antibody
Product Specific Notices for Lactase-like Protein/LCTL Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...